Modulation of alternative splicing induced by paclitaxel in human lung cancer

Paclitaxel is utilized as the first-line chemotherapeutic regimen for the majority of advanced non-small-cell lung carcinoma. However, whether paclitaxel could suppress cancer progression through modulating RNA alternative splicing remains largely unknown. Here, we demonstrated the effects of paclit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Zhu, Ziran, Chen, Dan, Zhang, Wenjing, Zhao, Jinyao, Zhi, Lili, Huang, Fang, Ji, Haoyu, Zhang, Jinrui, Liu, Han, Zou, Lijuan, Wang, Yang
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5924756/
https://ncbi.nlm.nih.gov/pubmed/29706628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0539-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados